BMS-8

• Description:

  BMS-8 is a novel inhibitor of the PD-1/PD-L1 interaction (IC50: 7.2 μM) by binding directly to PD-L1 and inducing the formation of PD-L1 homodimers.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  494.429

• Molecular Formula:

  C27H28BrNO3

• Notes:

  Research use only, not for human use.

• Receptor:

  Wnt/beta-catenin

• CAS Number:

  1675201-90-7